title: A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy.
abstract: This article presents a case of a 14-year-old female twin with schizophrenia who developed severe catatonia following treatment with olanzapine. Under a combined treatment with amantadine, electroconvulsive therapy (ECT), and (currently) ziprasidone alone she improved markedly. Severity and course of catatonia including treatment response were evaluated with the Bush-Francis Catatonia Rating Scale (BFCRS). This case report emphasizes the benefit of ECT in the treatment of catatonic symptoms in an adolescent patient with schizophrenic illness.
authors.affiliation: Clinic for Child and Adolescent Psychiatry, Neurology and Psychotherapy, University of Rostock, Germany.
authors.forename: Frank
authors.initials: F
authors.lastname: Häßler
authors.forename: Olaf
authors.initials: O
authors.lastname: Reis
authors.forename: Steffen
authors.initials: S
authors.lastname: Weirich
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Höppner
authors.forename: Birgit
authors.initials: B
authors.lastname: Pohl
authors.forename: Johannes
authors.initials: J
authors.lastname: Buchmann
mesh_terms: D000293:Adolescent; D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use*; D002389:Catatonia / Q000139:chemically induced* / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D003131:Combined Modality Therapy; D003402:Creatine Kinase / Q000097:blood; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000627:therapeutic use; D004200:Diseases in Twins / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D057915:Drug Substitution; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D009460:Neurologic Examination; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use; D000069348:Quetiapine Fumarate; D012008:Recurrence; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; C092292:ziprasidone; D000547:Amantadine; D003402:Creatine Kinase; D000077152:Olanzapine